Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse

Cephalalgia

Volumn 31, Issue 13, 2011, Pages 1368-1380

  Mathew, Rammya ^a   Andreou, Anna P ^a   Chami, Linda ^c   Bergerot, Astrid ^c   Van Den Maagdenberg, Arn Mjm ^b   Ferrari, Michel D ^b   Goadsby, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CACNA1A; CGRP; migraine; R192Q; trigeminal system

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FAMILIAL HEMIPLEGIC MIGRAINE; GANGLION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; STAINING; TRIGEMINAL NERVE;

AMINO ACID SUBSTITUTION; ANIMALS; AVIDIN; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CEREBELLAR ATAXIA; CODON; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; GANGLIA, SPINAL; GENE KNOCK-IN TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIGRAINE DISORDERS; MODELS, ANIMAL; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; NEURONS; POINT MUTATION; SPINAL CORD; TRIGEMINAL NERVE; TRIGEMINAL NUCLEI;

EID: 80054118085     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411418847     Document Type: Article

References (73)

1. The International Classification of Headache Disorders (second edition). Cephalalgia. 2004 ; 24 (Suppl 1). 1-160
2. van den Maagdenberg AMJM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences. Curr Opin Neurol. 2007 ; 20: 299-305 (Pubitemid 46743112)
3. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SMG, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996 ; 87: 543-552 (Pubitemid 26374327)
4. Haan J, Kors EE, van den Maagdenberg AM, Vanmolkot KR, Terwindt GM, Frants RR, et al. Toward a molecular genetic classification of familial hemiplegic migraine. Curr Pain Headache Rep. 2004 ; 8: 238-243 (Pubitemid 38915111)
5. Alonso I, Barros J, Tuna A, Seixas A, Coutinho P, Sequeiros J, et al. A novel R1347Q mutation in the predicted voltage sensor segment of the P/Q-type calcium-channel alpha-subunit in a family with progressive cerebellar ataxia and hemiplegic migraine. Clin Genet. 2004 ; 65: 70-72 (Pubitemid 38111407)
6. Kors EE, Vanmolkot KR, Haan J, Frants RR, van den Maagdenberg AM, Ferrari MD. Recent findings in headache genetics. Curr Opin Neurol. 2004 ; 17: 283-288 (Pubitemid 38720980)
7. Tottene A, Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, et al. Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Nat Acad Sci USA. 2002 ; 99: 13284-13289
8. van den Maagdenberg AMJM, Pietrobon D, Pizzorusso T, Kaja S, Broos LAM, Cesetti T, et al. A Cacna1a knock-in migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004 ; 41: 701-710 (Pubitemid 38326833)
9. Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, Santello M, et al. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron. 2009 ; 61: 762-773
10. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994 ; 117: 199-210 (Pubitemid 24103394)
11. Hadjikhani N, Sanchez del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Nat Acad Sci USA. 2001 ; 98: 4687-4692 (Pubitemid 32295037)
12. van de Ven RC, Kaja S, Plomp JJ, Frants RR, van den Maagdenberg AM, Ferrari MD. Genetic models of migraine. Arch Neurol. 2007 ; 64: 643-646 (Pubitemid 46789830)
13. Shields KG, Storer RJ, Akerman S, Goadsby PJ. Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat. Neuroscience. 2005 ; 135: 203-212 (Pubitemid 41219749)
14. Xiao Y, Richter JA, Hurley JH. Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling. Mol Pain. 2008 ; 4: 12-12
15. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990 ; 28: 183-187 (Pubitemid 20244522)
16. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993 ; 33: 48-56 (Pubitemid 23009909)
17. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008 ; 372: 2115-2123
18. Ho T, Mannix L, Fan X, Assaid C, Furtek C, Jones C, et al. Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology. 2008 ; 70: 1004-1012
19. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004 ; 350: 1104-1110 (Pubitemid 38298990)
20. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002 ; 22: 54-61 (Pubitemid 34626025)
21. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural blood vessel diameter in the anaesthetized rat. Cephalalgia. 1997 ; 17: 518-524 (Pubitemid 27248489)
22. Williamson DJ, Shepheard SL, Hill RG, Hargreaves RJ. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. Eur J Pharmacol. 1997 ; 328: 61-64 (Pubitemid 27241396)
23. Akerman S, Williamson D, Goadsby PJ. Voltage-dependent calcium channels are involved in neurogenic dural vasodilation via a pre-synaptic transmitter release mechanism. Br J Pharmacol. 2003 ; 140: 558-566 (Pubitemid 37330500)
24. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol. 2004 ; 142: 1171-1181 (Pubitemid 39093014)
25. Fischer MJ, Koulchitsky S, Messlinger K. The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci. 2005 ; 25: 5877-5883 (Pubitemid 40911418)
26. Goadsby PJ, Lipton RB, Ferrari MD. Migraine- current understanding and treatment. N Eng J Med. 2002 ; 346: 257-270
27. Classey JD, Bartsch T, Goadsby PJ. Immunohistochemical examination of 5HT1B, 5HT1D and 5HT1F receptor expression in rat trigeminal ganglion (TRG) and dorsal root ganglia (DRG) neurons. Cephalalgia. 2002 ; 22: 595-596
28. Mathew R, Chami L, Bergerot A, van den Maagdenberg AMJM, Ferrari MD, Goadsby PJ. Reduced expression of calcitonin gene related peptide (CGRP) in mice with the familial hemiplegic migraine (FHM) 1 mutation. Cephalalgia. 2007 ; 27: 1190-1190
29. Classey JD, Knight YE, Goadsby PJ. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Res. 2001 ; 907: 117-124 (Pubitemid 32595518)
30. Paxinos G, Franklin KBJ The mouse brain in stereotaxic coordinates. 20032 nd ednLondon: Academic Press. London: Academic Press ; 2003 :
31. Schutz B, Mauer D, Salmon AM, Changeux JP, Zimmer A. Analysis of the cellular expression pattern of beta-CGRP in alpha-CGRP-deficient mice. J Comp Neurol. 2004 ; 476: 32-43 (Pubitemid 38880231)
32. Salmon AM, Damaj I, Sekine S, Picciotto MR, Marubio L, Changeux JP. Modulation of morphine analgesia in alphaCGRP mutant mice. Neuroreport. 1999 ; 10: 849-854 (Pubitemid 29393834)
33. Price TJ, Flores CM. Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. J Pain. 2007 ; 8: 263-272 (Pubitemid 46366858)
34. Deumens R, Lubbers M, Jaken RJ, Meijs MF, Thurlings RM, Honig WM, et al. Mice lacking L1 have reduced CGRP fibre in-growth into spinal transection lesions. Neurosci Lett. 2007 ; 420 (3). 277-281 (Pubitemid 46856018)
35. Zhang L, Hoff AO, Wimalawansa SJ, Cote GJ, Gagel RF, Westlund KN. Arthritic calcitonin/alpha calcitonin gene-related peptide knock-out mice have reduced nociceptive hypersensitivity. Pain. 2001 ; 89: 265-273 (Pubitemid 32146406)
36. Sugimoto T, Fujiyoshi Y, Xiao C, He YF, Ichikawa H. Central projection of calcitonin gene-related peptide (CGRP)- and substance P (SP)-immunoreactive trigeminal primary neurons in the rat. J Comp Neurol. 1997 ; 378: 425-442 (Pubitemid 27061466)
37. Simonetti M, Fabbro A, D'Arco M, Zweyer M, Nistri A, Giniatullin R, et al. Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin. Mol Pain. 2006 ; 2: 11-11
38. Hoskin KL, Goadsby PJ. Exposure and isolation of the superior sagittal sinus elicits Fos in the trigeminal nucleus caudalis and dorsal horn of the cervical spinal cord: how long should you wait?. Brain Res. 1999 ; 824: 133-135 (Pubitemid 29222895)
39. Rohn TA, Ralvenius WT, Paul J, Borter P, Hernandez M, Witschi R, et al. A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic pain. J Immunol. 2010 ; 186: 1769-1780
40. Aita M, Maeda T, Seo K. The effect of neonatal capsaicin treatment on the CGRP-immunoreaction in the trigeminal subnucleus caudalis of mice. Biomed Res. 2008 ; 29: 33-42 (Pubitemid 351425819)
41. Kline P The handbook of physiological testing. 19992 nd ednLondon: Routledge. London: Routledge ; 1999 :
42. Siegel S Non-parametric statistics for the behavioural sciences. Kogakusha, Tokyo: McGraw-Hill ; 1956 :
43. Llinas R, Sugimori M, Hillman DE, Cherksey B. Distribution and functional significance of the P-type, voltage-dependent Ca2+ channels in the mammalian central nervous system. Trends Neurosci. 1992 ; 15: 351-355
44. Dunlap K, Luebke JI, Turner TJ. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci. 1995 ; 18: 89-98
45. Westenbroek RE, Sakurai T, Elliott EM, Hell JW, Starr TVB, Snutch TP, et al. Immunochemical identification and subcellular distribution of the alpha(1a) subunits of brain calcium channels. J Neurosci. 1995 ; 15: 6403-6418
46. Zhang Z, Winborn CS, Marquez de Prado B, Russo AF. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci. 2007 ; 27: 2693-2703 (Pubitemid 46393588)
47. Park JW, Moon HS, Akerman S, Holland PR, Lasalandra M, Andreou AP, et al. Blunted trigeminovascular nociceptive responses in mice with the CACNA1A mutation. Headache. 2010 ; 50 (Suppl 1). 61-61
48. Moon HS, Park JW, Akerman S, Holland PR, Andreou AP, Lasalandra M, et al. Altered responses in the descending modulatory system of transgenic mice with a CACNA1A mutation. Headache. 2010 ; 50 (Suppl 1). 6-7
49. Goadsby PJ. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches. Drugs. 2005 ; 65: 2557-2567 (Pubitemid 43049952)
50. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett. 1985 ; 62: 131-136 (Pubitemid 16205735)
51. Smith D, Hill RG, Edvinsson L, Longmore J. An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia. 2002 ; 22: 424-431 (Pubitemid 36606061)
52. Villalon CM, Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther. 2009 ; 124: 309-323
53. Sixt ML, Messlinger K, Fischer MJ. Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain. 2009 ;: 3134-3141
54. Haan J, Terwindt GM, Bos PL, Ophoff RA, Frants RR, Ferrari MD, et al. Familial hemiplegic migraine in The Netherlands. Clin Neurol Neurosurg. 1994 ; 96: 244-249 (Pubitemid 24260303)
55. Thomsen LL, Ostergaard E, Romer SF, Andersen I, Eriksen MK, Olesen J, et al. Sporadic hemiplegic migraine is an aetiologically heterogeneous disorder. Cephalalgia. 2003 ; 23: 921-928 (Pubitemid 37352630)
56. Hansen JM, Thomsen LL, Olesen J, Ashina M. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype. Neurology. 2008 ; 71: 841-847
57. Hansen JM, Thomsen LL, Marconi R, Casari G, Olesen J, Ashina M. Familial hemiplegic migraine type 2 does not share hypersensitivity to nitric oxide with common types of migraine. Cephalalgia. 2008 ; 28: 367-375 (Pubitemid 351341452)
58. Hansen JM, Thomsen LL, Olesen J, Ashina M. Familial hemiplegic migraine type 1 shows no hypersensitivity to nitric oxide. Cephalalgia. 2008 ; 28: 496-505 (Pubitemid 351502557)
59. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport. 1993 ; 4: 1027-1030 (Pubitemid 23242637)
60. Read SJ, Hirst WD, Upton N, Parsons AA. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res. 2001 ; 891: 69-77 (Pubitemid 32115496)
61. Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG. Randomized double blind, placebo-controlled proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia. 2009 ; 29: 742-750
62. Hauge AW, Asghar MS, Schytz HW, Christensen K, Olesen J. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol. 2009 ; 8: 718-723
63. Edvinsson L, Eftekhari S, Salvatore CA, Warfvinge K. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat. Mol Cell Neurosci. 2011 ; 46: 333-339
64. Ajima H, Kawano Y, Takagi R, Aita M, Gomi H, Byers MR, et al. The exact expression of glial fibrillary acidic protein (GFAP) in trigeminal ganglion and dental pulp. Arch Histol Cytol. 2001 ; 64: 503-511 (Pubitemid 34131939)
65. Schafers M, Geis C, Svensson CI, Luo ZD, Sommer C. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci. 2003 ; 17: 791-804 (Pubitemid 36315249)
66. Taylor SJ, Rosenzweig ES, McDonald JW, Sakiyama-Elbert SE. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release. 2006 ; 113: 226-235 (Pubitemid 43963190)
67. Vamos E, Pardutz A, Fejes A, Tajti J, Toldi J, Vecsei L. Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus. Eur J Pharmacol. 2009 ; 621: 33-37
68. Andres KH, During Mv, Muszynski K, Schmidt RF. Nerve fibres and their terminals in the dura mater encephali of the rat. Anat Embryol. 1987 ; 175: 289-301 (Pubitemid 17111180)
69. Wolff HG Headache and other head pain. 19481 st ednNew York: Oxford University Press. New York: Oxford University Press ; 1948 :
70. Strassman A, Mason P, Moskowitz M, Maciewicz R. Response of brainstem trigeminal neurons to electrical stimulation of the dura. Brain Res. 1986 ; 379: 242-250 (Pubitemid 16012393)
71. Tottene A, Pivotto F, Fellin T, Cesetti T, van den Maagdenberg AM, Pietrobon D. Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem. 2005 ; 280: 17678-17686 (Pubitemid 41389004)
72. Eikermann-Haerter K, Dilekoz E, Kudo C, Savitz SI, Waeber C, Baum MJ, et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest. 2009 ; 119: 99-109
73. Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain. 2002 ; 125: 1379-1391 (Pubitemid 34587146)